Malaysian Science Minister Woos Foreign Biotechs To Relocate
This article was originally published in PharmAsia News
Malaysia's science minister called on foreign investors to take a good look at his country and the incentives it offers for biotechs to relocate or at least establish a presence. Datuk Maximum Ongkili, Science, Technology and Innovation minister, outlined Malaysia's advantages at the Bio International Convention 2008 in the United States. As head of an 82-member Malaysian delegation, Ongkili said that in addition to providing an existing biotech industry, his country is willing to consider additional incentives for biotech-based investments and collaborations. (Click here for more
You may also be interested in...
New report shows average out-of-pocket cost per prescription of $10.67 in 2019 was unchanged from 2018. But while the number of dispensed drugs barely increased, sales jumped more than 5%.
The merger between virtual care companies Teladoc and Livongo will offer individuals a wide range of tech-enabled care during a time when telehealth continues to grow.
Regeneron's antibody cocktail for SARS-Cov-2 is largely in holding mode for now, but the company announced progress on other fronts including for Dupixent in COPD and the NGF inhibitor fasinumab.